BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 16625143)

  • 1. Rituximab (Rituxan) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2006 Apr; 48(1233):34-5. PubMed ID: 16625143
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab for rheumatoid arthritis.
    Palylyk-Colwell E; McGahan L
    Issues Emerg Health Technol; 2006 Sep; (89):1-4. PubMed ID: 17014062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab: new indication. In rheumatoid arthritis: for a few patients, with close monitoring.
    Prescrire Int; 2007 Oct; 16(91):186-8. PubMed ID: 17926823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach.
    Devine EB; Alfonso-Cristancho R; Sullivan SD
    Pharmacotherapy; 2011 Jan; 31(1):39-51. PubMed ID: 21182357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infliximab for therapy of rheumatoid arthritis].
    Amano K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():517-20. PubMed ID: 15799410
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rituximab (MabThera) as treatment of active rheumatoid arthritis].
    El Fassi D; Nielsen CH; Bendtzen K
    Ugeskr Laeger; 2006 Nov; 168(47):4079-81. PubMed ID: 17134602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rituximab treatment of rheumatoid arthritis: new evidence].
    Nasonov EL
    Ter Arkh; 2009; 81(6):82-91. PubMed ID: 19663200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
    D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
    Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences with infliximab in the treatment of active rheumatoid arthritis and spondyloarthropathy].
    Dahlin J; Sørensen SF
    Ugeskr Laeger; 2003 Nov; 165(48):4646-9. PubMed ID: 14677464
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab for the treatment of rheumatoid arthritis.
    Schuna AA
    Pharmacotherapy; 2007 Dec; 27(12):1702-10. PubMed ID: 18041890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab: new drug. Rheumatoid arthritis: another 'mab', no therapeutic advantage.
    Prescrire Int; 2009 Oct; 18(103):198-201. PubMed ID: 19882783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidelines for usage of biological agents for treatment of rheumatoid arthritis].
    Takeuchi T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():444-7. PubMed ID: 15799396
    [No Abstract]   [Full Text] [Related]  

  • 13. [B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].
    Yukawa N; Mimori T
    Clin Calcium; 2007 Apr; 17(4):569-76. PubMed ID: 17404487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab (Actemra) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2010 Jun; 52(1340):47-8. PubMed ID: 20539266
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context.
    Soriano ER; Galarza-Maldonado C; Cardiel MH; Pons-Estel BA; Massardo L; Caballero-Uribe CV; Achurra-Castillo AF; Barile-Fabris LA; Chávez-Corrales J; Díaz-Coto JF; Esteva-Spinetti MH; Guibert-Toledano M; Palazuelos FI; Keiserman MW; Lomonte AV; Mota LM; Pineda Villaseñor C; Alarcón GS;
    Rheumatology (Oxford); 2008 Jul; 47(7):1097-9. PubMed ID: 18463144
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on rituximab.
    Eisenberg R
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv55-7. PubMed ID: 16239389
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical image: hidden costs of anti-tumor necrosis factor alpha therapy.
    Mulherin D; Sheeran TP
    Arthritis Rheum; 2003 Mar; 48(3):868. PubMed ID: 12632461
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate.
    Owczarczyk K; Hellmann M; Fliedner G; Röhrs T; Maizus K; Passon D; Hallek M; Rubbert A
    Ann Rheum Dis; 2008 Nov; 67(11):1648-9. PubMed ID: 18854518
    [No Abstract]   [Full Text] [Related]  

  • 19. Observational cohort studies and well controlled clinical trials--we need them both!
    Furst DE
    J Rheumatol; 2004 Aug; 31(8):1476-7. PubMed ID: 15290723
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoimmune diseases. The B cell slayer.
    Matthews R
    Science; 2007 Nov; 318(5854):1232-3. PubMed ID: 18033858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.